Status:
Awaiting development
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:
Criteria within the VPAG met as a significant indication. 
Process:
STA Standard
ID number:
6675

Project Team

Project lead
Emily Richards

Timeline

Key events during the development of the guidance:

Date Update
27 January 2026 Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in early December 2026. These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission.
12 November 2025 Topic selection
03 November 2025 Awaiting development. Status change linked to topic prioritisation decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual